Influence of the parental virus strain on the virulence and immunogenicity of recombinant vaccinia viruses expressing HBV preS2-S protein or VZV glycoprotein I

Vaccine

Volumn 14, Issue 11, 1996, Pages 1045-1052

  Kutinová, Luda ^a   Ludvíková, Viera ^a   Kryštofová, Jitka ^a   Otavová, Marie ^b   Simonová, Věra ^b   Němečková, Šárka ^a   Hainz, Petr ^a   Vonka, Vladimír ^a  

^a INSTITUTE OF HEMATOLOGY AND BLOOD TRANSFUSION   (Czech Republic)

^b Sevac as   (Czech Republic)

Author keywords

Immunogenicity; Vaccinia virus recombinants; Virulence

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; VACCINE; VIRUS GLYCOPROTEIN;

ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; HEPATITIS B VIRUS; IMMUNIZATION; IMMUNOGENICITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; VACCINIA VIRUS; VIRULENCE; VIRUS RECOMBINANT;

EID: 0030218223     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0264-410X(96)00008-4     Document Type: Article

References (27)

1. 1 Hashizume, S., Yoshizawa, H., Morita, M. and Suzuki, K. Properties of attenuated mutant of vaccinia virus, LC16m8, derived from Lister strain. In: Vaccinia Viruses as Vectors for Vaccinia Antigens (Ed. Quinnan, G.V.), Elsevier Science Publishing, Amsterdam, 1985, pp. 87-99
2. 2 Morita, M., Suzuki, K., Yasuda, A. et al. Recombinant vaccinia virus LC16m0 or LC16m8 that express hepatitis B surface antigen while preserving the attenuation of the parental virus strain. Vaccine 1987, 5, 65-70
3. 3 Altenburger, W., Suter, C.P. and Altenburger, J. Partial deletions of the human host range in the attenuated vaccinia virus MVA. Archs Virol. 1989, 105, 15-27
4. 4 Rodriguez, D., Rodriguez, J.R., Rodriguez, J.F., Trauber, D. and Esteban, M. Highly attenuated vaccinia virus mutants for the generation of safe recombinant viruses. Proc. Natl Acad. Sci. USA 1989, 86, 1287-1291
5. 5 Lee, M.S., Ross, J.M., McGuigan, L.C. et al. Molecular attenuation of vaccinia virus: mutant generation and animal characterization. J. Virol. 1992, 66, 2617-2630
6. 6 Tartaglia, J., Perkus, M.E., Taylor, J. et al. NYVAC: A highly attenuated strain of vaccinia virus. Virology 1992, 108, 217-232
7. 7 Morgan, A.J., Mackett, S., Finerty, S., Arrand, J.R., Scullion, F.T. and Epstein, M.A. Recombinant vaccinia virus expressing Epstein-Barr virus gp340 protects cottontop tamarins against EB virus-induced malignant lymphomas. J. Med. Virol. 1988, 25, 189-195
8. 8 Grigorieva, I.M., Grigoriev, V.G., Zakharova, L.G., Pashvykina, G.V., Shevlyagin, V. and Altstein, A. lmmunogenicity of recombinant vaccinia viruses expressing hepatitis B virus surface antigen in mice. Immunol. Lett. 1993, 36, 267-272
9. 9 Konishi, E., Pincus, S., Paoletti, E., Laegreid, W.W., Shope, R.E. and Mason, P. A highly attenuated host range restricted vaccinia virus strain, NYVAC, encoding the prM, E, and NS1 genes of Japanese encephalitis virus prevents JEV viremia in swine. Virology 1992, 190, 454-458
10. 10 Cox, W.I., Tartaglia, J. and Paoletti, E. Induction of cytotoxic T lymphocytes by recombinant canarypox (ALVAC) and attenuated vaccinia (NYVAC) viruses expressing the HIV-1 envelope glycoprotein. Virology 1993, 195, 845-850
11. 11 Kutinová, L., Ludvíková, V., Simonové, V. et al. Search for optimal parent for recombinant vaccinia virus vaccines. Study of three vaccinia virus vaccinal strains and several virus lines derived from them. Vaccine 1995, 13, 487-493
12. 12 Kutinová, L., Němečková, Š., Hamšíková, E. et al. A recombinant vaccinia virus expressing hepatitis B virus middle surface protein. Restricted expression of HBV antigens in human diploid cells. Archs Virol. 1990, 112, 181-193
13. 13 Němečková, Š., Kutinová, L., Hamšíková, E. et al. Synthesis and immunogenicity of hepatitis B virus envelope antigen experessed by recombinant vaccinia virus. Finding of reiteration signal in the C-terminal portion of the preS1 domain of subtype adyw. Archs Virol. 1991, 121, 29-41
14. 14 Ludvíková, V., Kunke, D., Hamšíková, E., Kutinová, L. and Vonka, V. Immunogenicity in mice of varicella-zoster virus glycoprotein I expressed by a vaccinia virus-varicella-zoster virus recombinant. J. Gen. Virol. 1991, 72, 1445-1449
15. 15 Galibert, F., Mandrat, E., Fitoussi, F., Tiollais, P. and Charnay, P. Nucleotide sequence of the hepatitis B virus genome (subtype ayw) cloned in E. coli. Nature 1979, 281, 646-650
16. 16 Pourcel, L., Louise, S., Gervais, M., Chenciner, N., Dubois, M.F. and Tiollais, P. Transcription of the hepatitis surface gene in mouse transformed with cloned viral DNA. J. Virol. 1982, 42, 100-105
17. 17 Perkus, M.E., Panicali, D., Mercer, S. and Paoletti, E. Insertion and deletion mutants of vaccinia virus. Virology 1986, 152, 285-297
18. 18 Kutinová, L., Němečková, Š., Hamšíková, E. et al. Hepatitis B virus proteins expressed by recombinant vaccinia viruses: influence of preS2 sequence on expression surface and nucleocapsid proteins in human diploid cells. Arch. Virol. 1994, 134, 1-15
19. 19 Reed, L.J. and Muench, J. A simple method of estimating fifty percent endpoints. Am. J. Hyg. 1938, 27, 493-497
20. 20 Joklik, W.K. The purification of four strains of poxvirus. Virology 1962, 18, 9-18
21. 21 Hamšíková, E., Závadová, H., Kutinová, L. et al. Priming effect of recombinant vaccinia virus coding for the middle hepatitis B surface antigen. Archs Virol. 1990, 113, 283-289
22. 22 Cadoz, M., Strady, A., Meignier, B. et al. Immunization with canarypox virus expressing rabies glycoprotein. Lancet 1992, 339, 1429-1432
23. 23 Taylor, J., Weinberg, R., Tartaglia, J. et al. Nonreplicating viral vectors as potential vaccines: recombinant canarypox virus expressing measles virus fusion (F) and hemagglutinin (HA) glycoproteins. Virology 1992, 187, 321-328
24. 24 Buller, R.M.L., Smith, G.L., Cremer, K., Notkins, A.L. and Moss, B. Decreased virulence of recombinant vaccinia virus expression vectors is associated with a thymidine kinase-negative phenotype. Nature 1985, 317, 813-815
25. 25 Buller, R.M.L. and Palumbo, G.J. Safety and attenuation of vaccinia virus. In: Recombinant Poxviruses (Eds Binns, M. and Smith, G.). CRC Press, London, 1992, pp. 235-267
26. 26 Shida, H., Hinuma, Y., Hatanaka, M. et al. Effects and virulence of recombinant vaccinia viruses derived from attenuated strains that express the human T-cell leukemia virus type I envelope gene. J. Virol. 1988, 62, 4474-4480
27. 27 Ludvíková, V., Kutinová, L., Simonová, V. and Otavová, M. Evaluation of various virulence tests with low virulence vaccinia virus in mice. Biologicals 1994, 22, 187-190